Evolutionary Genomics

Evolutionary Genomics FCF Conversion

The FCF Conversion Rate (FCF/EBITDA) of Evolutionary Genomics (FNAM) as of Nov 18, 2026 is 33.12 %. In the previous year, FCF Conversion Rate (FCF/EBITDA) was 56.66 % — a change of -41.54% (lower).

FCF Conversion

33.12 %

YoY

-41.54%

Last updated:

FCF Conversion Rate (FCF/EBITDA) of Evolutionary Genomics is 2022 33.12 % . FCF Conversion Rate (FCF/EBITDA) of Evolutionary Genomics was 2021 56.66 % . It decreases by -41.54% lower compared to the previous year.

The Evolutionary Genomics FCF Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF Conversion
Date
FCF Conversion
Jan 1, 2015
242.39 USD
Jan 1, 2016
105.00 USD
Jan 1, 2017
218.17 USD
Jan 1, 2018
68.16 USD
Jan 1, 2019
78.92 USD
Jan 1, 2020
134.20 USD
Jan 1, 2021
56.66 USD
Jan 1, 2022
33.12 USD
The Evolutionary Genomics FCF Conversion history
YEARFCF ConversionYoY
33.12 %-41.54%
56.66 %-57.78%
134.20 %+70.03%
78.92 %+15.79%
68.16 %-68.76%
218.17 %+107.78%
105.00 %-56.68%
242.39 %+153.33%
95.68 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Evolutionary Genomics Stock analysis

What does Evolutionary Genomics do? Evolutionary Genomics, Inc. generates revenue through the identification and validation of genes impacting commercially valuable traits in crops for the agriculture industry. The company utilizes its Adapted Traits Platform (ATP) to identify genes that control important traits in plants and animals, focusing on yield increases in corn and rice, drought tolerance, sugar content in tomatoes, and pest/disease resistance in soybeans, cassava, beans, tomatoes, and cotton. The firm applies ATP in research projects for agricultural clients seeking improved crop performance. The company targets agricultural industry clients who require gene-based solutions for enhancing crop traits such as yield, drought tolerance, and pest resistance. The Adapted Traits Platform (ATP) is central to the company's product offering, enabling throughput molecular evolution analysis through non-synonymous site (Ka) and synonymous site (Ks) analysis to identify positively selected genes. This platform identifies genes that have successfully adapted to impart new or improved traits in agricultural crops. The firm's research projects include specific applications like yield increases in corn and rice, drought tolerance in crops, and pest resistance in soybeans, cassava, beans, tomatoes, and cotton. Agricultural companies and research institutions are the primary buyers of these gene identification services. Evolutionary Genomics, Inc. focuses on the agriculture industry, specifically targeting clients who need gene validation for crop improvement. The company's services are used to identify genes responsible for commercially valuable traits such as yield, drought tolerance, and pest resistance. The firm's ATP platform is applied in research projects for crops including corn, rice, soybeans, cassava, beans, tomatoes, and cotton. Agricultural clients seeking to enhance their crop traits through gene-based solutions are the key market segment for the company's offerings. Evolutionary Genomics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolutionary Genomics stock

FCF Conversion Rate (FCF/EBITDA) of Evolutionary Genomics is 33.12 % in 2022.

FCF Conversion Rate (FCF/EBITDA) of Evolutionary Genomics changed from 56.66 % to 33.12 %, representing a -41.54% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of FCF Conversion Rate (FCF/EBITDA) Evolutionary Genomics since 2006 – with annual values, charts, and detailed analysis.

FCF conversion measures how effectively EBITDA converts to free cash flow. Higher conversion indicates efficient capital allocation and low maintenance costs.

A 'good' varies by industry and company stage. On Eulerpool, you can compare FCF Conversion Rate (FCF/EBITDA)'s Evolutionary Genomics with sector peers and the industry average to assess whether it is attractive.

To evaluate FCF Conversion Rate (FCF/EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for FCF Conversion Rate (FCF/EBITDA).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Evolutionary Genomics

All Key Metrics — Evolutionary Genomics